Skip to main content
. 2018 Apr 10;2018:8303609. doi: 10.1155/2018/8303609

Table 1.

Patients' baseline characteristics.

Variates Group I Group II Group III P
n 50 50 49 /
Male, n (%) 28 (56.0) 31 (62.0) 37 (75.5) 0.116
Age, years 68.6 ± 8.8 68.6 ± 9.4 68.5 ± 9.5 0.998
BMI, kg/m2 25.1 ± 3.0 24.6 ± 2.6 24.9 ± 3.1 0.767
HBP, n (%) 41 (82.0) 43 (86.0) 35 (71.4) 0.175
Smoking history, n (%) 18 (36.0) 17 (34.0) 24 (49.0) 0.256
Family history, n (%) 33 (66.0) 33 (66.0) 25 (51.0) 0.212
Total cholesterol, mmol/L 4.1 ± 1.2 3.9 ± 0.9 3.9 ± 0.9 0.571
Total triglyceride, mmol/L 1.3 ± 1.7 1.3 ± 1.7 1.3 ± 1.7 0.999
HDL-C, mmol/L 1.2 ± 1.3 1.2 ± 1.2 1.2 ± 1.2 0.695
LDL-C, mmol/L 2.3 ± 1.6 2.1 ± 1.3 2.0 ± 1.4 0.216
hsCRP, mg/L 1.3 ± 4.3 1.8 ± 5.4 1.3 ± 4.0 0.495
Fasting blood glucose, mmol/L 7.1 ± 1.4 7.2 ± 1.3 5.3 ± 1.2 <0.001
Blood urea nitrogen, mmol/L 5.3 (4.6, 6.5) 6.0 (5.0, 7.6) 5.1 (3.8, 6.1) 0.003
Creatinine, µmol/L 66.5 (59.8, 76.3) 72.9 (62.5, 89.4) 73.0 (62.0, 85.0) 0.046
ALT, U/L 18.5 (13.0, 25.8) 17.5 (13.0, 25.0) 18.0 (14.0, 23.5) 0.694
AST, U/L 19.5 (17.0, 23.3) 19.0 (15.8, 23.3) 20.0 (17.5, 23.5) 0.209
CK-MB, ng/mL 1.9 (1.1, 3.2) 2.0 (1.3, 3.6) 1.8 (1.2, 3.8) 0.846
Troponin-T, ng/mL 0.01 (0.01, 0.05) 0.01 (0.00, 0.03) 0.01 (0.00, 0.04) 0.223
Lesion arteries, n 2.0 (2.0, 3.0) 3.0 (2.0, 4.0) 2.0 (1.0, 3.0) 0.151
Implanted stents, n 1.0 (1.0, 1.0) 1.0 (1.0, 2.0) 1.0 (1.0, 2.0) 0.388
Gensini Score 27.7 ± 2.0 28.1 ± 2.4 28.7 ± 1.9 0.970
Volume of contrast media, mL 150.0 (150.0, 150.0) 150.0 (150.0, 150.0) 150.0 (150.0,150.0) 0.570

Normal data are represented by mean ± SD, nonnormal variates are repressed as median (interquartile range), and categorical variables are expressed as percentage. BMI: body mass index; HBP: high blood pressure; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; hsCRP: high sensitivity C-reactive protein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CK-MB: creatine kinase isoenzyme MB.